For women facing a mastectomy, the path to breast reconstruction is a deeply personal journey fraught with complex trade-offs. While medical advancements have expanded the options available, the decision-making process remains a significant hurdle, particularly for historically marginalized communities. A groundbreaking study published in the September issue of Plastic and Reconstructive Surgery—the official medical journal of the American Society of Plastic Surgeons (ASPS)—sheds new light on the unique priorities of African American women, offering a roadmap for more equitable and effective healthcare communication.
Main Facts: A New Approach to Informed Consent
The study, led by Dr. Ronnie L. Shammas of Memorial Sloan Kettering Cancer Center, sought to quantify the factors that drive decision-making among African American patients. In an era where "shared decision-making" is the gold standard of care, the research team employed an innovative methodology known as Adaptive Choice-Based Conjoint (ACBC) analysis.
Unlike traditional surveys, which may only ask patients to rank preferences in a vacuum, ACBC analysis forces individuals to confront the real-world trade-offs inherent in surgical procedures. By presenting patients with realistic scenarios—complete with visual aids showing potential scarring and aesthetic outcomes—the researchers were able to peel back the layers of patient values.
The study findings reveal that for African American women, the primary driver for choosing a reconstruction method is the risk of major complications, which held a 26% relative importance in their decision-making. The aesthetic appearance of the reconstructed breast followed at 15%. Other variables, including recovery time, the necessity of secondary "touch-up" surgeries, and the long-term impact of autologous reconstruction (using the patient’s own tissue) on abdominal health, also played significant roles in the final decision.
Chronology: Understanding the Research Process
The research was a collaborative effort involving experts from Memorial Sloan Kettering Cancer Center, the University of North Carolina, and Duke University. The study followed a rigorous, multi-phase methodology:
- Tool Development: The research team, including Drs. Anna Hung and Shelby Reed, designed an interactive ACBC tool specifically tailored to provide clear information on the two primary reconstruction modalities: implant-based reconstruction and autologous (flap) reconstruction.
- Participant Selection: The study enrolled 181 African American women. These participants were categorized into two groups: those undergoing mastectomy as a treatment for active breast cancer and those undergoing prophylactic (preventive) mastectomy due to high genetic risk.
- The Interactive Survey: Participants engaged with the ACBC tool, which simulated clinical outcomes. The tool provided photographic references to ensure patients had a realistic expectation of post-surgical appearance, including potential scarring.
- Data Synthesis: The researchers aggregated the choices made by the 181 women to determine the "relative importance" of various surgical attributes, effectively mapping the hierarchy of patient concerns.
- Clinical Interpretation: Finally, the team compared these findings against existing literature on the experiences of White patients to determine whether current clinical communication standards are sufficient to address the needs of African American women.
Supporting Data: Mapping the Patient Preference Landscape
The data yielded by the ACBC analysis provides a granular look at how patients weigh risks against outcomes. The study discovered a strong overall preference for implant-based reconstruction, with 85% of the cohort opting for this route.
Why Implants Won
The preference for implants was significantly higher among patients with fewer comorbidities (underlying health conditions) and those who had no history of previous surgical complications. Additionally, women undergoing preventive mastectomies were statistically more likely to choose implant-based reconstruction, likely reflecting a desire to minimize the total surgical burden and recovery time associated with more invasive flap procedures.
The Autologous Subset
Only 15% of the participants chose autologous reconstruction. However, the data surrounding this minority group is illuminating. One-quarter of those who chose flap reconstruction specifically cited a preference for the aesthetic appearance of the reconstructed breast over the look of an implant.
Crucially, the study identified the "threshold of risk" that these patients were willing to accept. Women choosing autologous surgery were comfortable with an increase of up to 8% in the risk of major complications and a 6% increase in the risk of abdominal morbidity. Once the projected risks exceeded these thresholds, the preference shifted back to implant-based reconstruction, demonstrating that these patients were not choosing blindly, but were engaging in a calculated risk-benefit analysis.
Official Responses: Bridging the Communication Gap
"Especially in light of policies emphasizing shared decision-making between patients and physicians, our findings highlight the need for tools to elicit treatment preferences and the importance of discussing treatment goals and preferences," says lead author Dr. Ronnie L. Shammas.
The sentiment is shared by senior author Dr. Clara N. Lee of the University of North Carolina. The research team emphasizes that the current clinical environment often fails to meet the needs of non-White patients. Previous studies have indicated that approximately 20% of patients report inadequate discussions regarding their reconstructive options—a rate that researchers suspect is disproportionately higher among African American women.
"We hope that this method can translate to the improved communication of patient values to the physician, and better inform a shared treatment decision," Dr. Shammas explained. The team’s findings were validated by the participants themselves: two-thirds of the women in the study described the ACBC exercise as "very or extremely helpful," suggesting that patients are eager for more structured, visual, and value-based communication tools.
Implications: A Call for Active Engagement
The implications of this study extend far beyond the operating room. By proving that African American women share many of the same priorities as their White counterparts—albeit with different weightings—the study challenges the medical community to move away from "one-size-fits-all" counseling.
Advancing Health Equity
The study is a milestone in breast reconstruction literature, serving as one of the first to focus specifically on the preferences of African American women. Historically, clinical studies in plastic surgery have often lacked adequate representation of minority groups. By isolating these preferences, the researchers have provided clinicians with the intelligence needed to initiate more inclusive and effective dialogues.
The Role of Technology in Shared Decision-Making
The success of the ACBC tool suggests that technology can be a powerful equalizer. When physicians use tools that visualize outcomes and calculate trade-offs, they reduce the ambiguity that often leads to patient dissatisfaction. This is particularly vital in the context of breast reconstruction, where the outcomes are as much about psychological well-being and body image as they are about oncological safety.
Future Clinical Practice
For surgeons, the message is clear: the "active engagement" of patients is not a luxury, but a clinical necessity. The purposeful solicitation of patient values is critical in historically marginalized groups who have historically reported lower rates of involvement in their own treatment decisions.
Moving forward, the authors conclude that incorporating such tools into routine clinical practice could significantly decrease the "decisional conflict" that many women face after a breast cancer diagnosis. By empowering patients with the ability to clearly state their priorities—whether they value a faster recovery or a more natural appearance—surgeons can ensure that the final treatment plan aligns with the patient’s life, values, and long-term goals.
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in professional information, software solutions, and services for the healthcare, tax and accounting, financial and corporate compliance, legal and regulatory, and corporate performance and ESG sectors. With annual revenues of €5.5 billion (2022) and operations in over 180 countries, the firm is dedicated to providing expert solutions that combine deep domain knowledge with specialized technology to help professionals make critical decisions every day.
About the Author
